
    
      Prospective, open labelled, RCT evaluating 72 cirrhotic patients with severe sepsis or septic
      shock (36 per arm) who were randomized to receive terlipressin plus alpha-adrenergic drugs or
      alpha-adrenergic drugs in the first 24h after septic shock diagnosis. Impact of terlipressin
      administration on shock reversal, changes in vasoactive systems, inflammatory response,
      incidence of variceal bleeding and type-1 HRS and ICU and hospital mortality was investigated
    
  